Origin and age of an ongoing radioactive contamination of soils near La hague reprocessing plant based on 239+240Pu/238Pu and 241Am/241Pu current ratios and 90Sr and Ln(III) soil contents.

Nuclear reprocessing plants are sources of environmental contamination by gaseous or liquid discharges. Numerous radionuclides are of concern, with actinides and 90Sr being the most radiotoxic. Environmental radioactivity survey programs mostly use γ-spectrometry to track contaminations because γ-spectrometry is very cost effective and can be carried out on raw samples. On the other hand, the determination of ß- or α-emitting radionuclides in environmental samples requires rather sophisticated analytical methods, and are thus dedicated to specific goals. However, measuring radionuclides such as Pu, Am, and Sr often provides more information about the presence of a current or prior contamination and on its origin, based on the isotopic composition of the samples. We found that the analysis of 241Pu, 239+240Pu, 241Am, and 90Sr of a few selected soil samples taken near the nuclear reprocessing plant of La Hague, France, revealed the presence of a previous environmental contamination originating from several incidents in La Hague site involving atmospheric transfer and leaks in flooded waste pits. The 241Am-241Pu dating method indicated a contamination period prior to 1983. The presence of elevated levels of light non-radioactive lanthanides and yttrium in the soil samples confirmed the involvement of cold fuel. Our results demonstrate how long-lived actinides are likely to reveal a long-term contamination of the environment by spent fuel. Our study indicates that there is a requirement to use more sophisticated tools than γ-spectrometry when surveying the environments surrounding industrial plants for nuclear power and nuclear reprocessing with a potential for the accidental release of radioactivity into the environment.

Radionuclides in the Environment in Switzerland: A Retrospective Study of Transfer from Soil to the Human Body.

Natural radionuclides are ubiquitous in the environment. In addition, artificial radionuclides are present in the Swiss environment after the fallout of the nuclear bomb tests of the 1950s and 1960s, after the accident of the Chernobyl nuclear power plant, or after authorized discharges from the Swiss nuclear power plants and research centres. These radionuclides can create a radiological hazard to the environment and humans because of the increased risk of cancer due to the ionizing radiation they produce. Here we show that some of these radionuclides have made their way from the air or the soil to the human body, where they target mostly the skeleton. However, the activity levels of 90 Sr, 239 Pu and 240 Pu, 226 Ra and 210 Pb/ 210 Po found in the human body remain very low and do not represent a public health issue at the current body burden.

Determination of 89Sr and 90Sr in fresh cow milk and raw urine using crystalline synthetic tunnel manganese oxides and layered metal sulfides.

89Sr and 90Sr are both fission products of high radiotoxicity, which can be released in significant amounts in the event of a nuclear accident. Radiostrontium isotopes will follow calcium all along the food chain and, after ingestion, accumulate in the bones. Therefore, it is imperative to be able to determine 89Sr and 90Sr in raw milk samples in case of an accidental situation to evaluate the dose given by both radionuclides to the population. Several methods exist for conducting 89Sr and 90Sr determination. However, most of them use at least one chromatographic step to purify strontium. This, unfortunately, increases the analytical time before the results can be released to the authorities. In addition, they often use liquid scintillation counting to determine the 89Sr and 90Sr activities, a method which can handle only one sample at a time. Here we propose using synthetic tunnel manganese oxides such as cryptomelane and todorokite and layered metal sulfides to selectively extract strontium from fresh milk and raw urine in a batch sorption method. We found that the method is very quick and yields very pure sources of (radio)-strontium, which can be counted in a proportional counter. Data (counts per minute) from the counter were fitted to a mathematical expression enabling the simultaneous determination of 89Sr and 90Sr. Because a proportional counter often has several drawers, it is typically possible to measure up to 16 samples at a time. Since cryptomelane is a binding phase easily synthesized in a large quantity, we anticipate that this technique could be an interesting alternative to conventional solid phase extraction chromatography methods.

Determination of 226Ra at low levels in environmental, urine, and human bone samples and 223Ra in bone biopsy using alpha-spectrometry and metrological traceability to 229Th/225Ra or 226Ra.

226Ra is a natural radioelement emitting α and γ radiations. It can be highly concentrated in TENORM materials from the petroleum or fertilizer industries. In Switzerland, 226Ra is currently a radioactive inheritance problem from the watch industry. Furthermore, 223Ra is a radium isotope used in nuclear medicine to treat bone metastasis. There exist several methods to measure radium using alpha or gamma spectrometry or using 222Rn emanation technique. The limitations of these methods are due to the required detection limits and the nature of the samples. When using alpha spectrometry to reach very low detection limits, critical technical hitches often arise because of the difficulties in separating radium from barium, in removing organics eluted from the separating chromatography column, and in plating radium. Moreover, overall chemical recovery of radium is often not reproducible, depending on the studies. Here we propose a method that separates radium from other alkaline-earth cations using cation exchange chromatography and selective complex formation by EDTA and DCTA. Radium is completely free of the 229Th tracer and its daughter products, particularly 225Ac. Organics from the column are removed in a further purification step so that radium can be plated with acceptable yields in a HCl/HNO3/ethanol solution. We successfully applied the method to soil, water, urine and human bone samples and further extended it to the determination of 223Ra in a bone biopsy, using 226Ra as an internal tracer.

Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids.

Antagonism of the CRTH2 receptor represents a very attractive target for a variety of allergic diseases. Most CRTH2 antagonists known to date possess a carboxylic acid moiety, which is essential for binding. However, potential acid metabolites O-acyl glucuronides might be linked to idiosynchratic toxicity in humans. In this communication, we describe a new series of compounds that lack the carboxylic acid moiety. Compounds with high affinity (K i < 10 nM) for the receptor have been identified. Subsequent optimization succeeded in reducing the high metabolic clearance of the first compounds in human and rat liver microsomes. At the same time, inhibition of the CYP isoforms was optimized, giving rise to stable compounds with an acceptable CYP inhibition profile (IC50 CYP2C9 and 2C19 > 1 µM). Taken together, these data show that compounds devoid of carboxylic acid groups could represent an interesting alternative to current CRTH2 antagonists in development.

Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.

A novel chemical class of potent chemoattractant receptor-homologous expressed on Th2 lymphocytes (CRTH2 or DP2) antagonists is reported. An initial and moderately potent spiro-indolinone compound ( 5) was found during a high-throughput screening campaign. Structure-activity relationship (SAR) investigation around the carboxylic acid group revealed that changes in this part of the molecule could lead to a reversal of functional activity, yielding weakly potent agonists. SAR investigation of the succinimide functional group led to the discovery of several single-digit nanomolar antagonists. The potency of these compounds was confirmed in a human eosinophil chemotaxis assay. Moreover, compounds ( R)- 58 and ( R)- 71 were shown to possess pharmacokinetic properties suitable for development as an orally bioavailable drug.

Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.

We report a novel chemical class of potent oxytocin receptor antagonists showing a high degree of selectivity against the closely related vasopressin receptors (V1a, V1b, V2). An initial compound, 7, was shown to be active in an animal model of preterm labor when administered by the intravenous but not by the oral route. Stepwise SAR investigations around the different structural elements revealed one position, the arenesulfonyl moiety, to be amenable to structural changes. Consequently, this position was used to introduce a variety of substituents to improve the physicochemical properties. Some of the resulting analogues were found to be superior to 7 both in terms of potency in vitro and aqueous solubility, which translated into significantly improved efficacy in the animal model after intravenous and oral administration. The best compound, 73, potently inhibited oxytocin-induced uterine contractions in nonpregnant rats and reduced spontaneous uterine contractions in late-term pregnant rats.